# A Clinical Study of Intravenous Immunoglobulin

> **NCT00468273** · PHASE3 · COMPLETED · sponsor: **FFF Enterprises** · enrollment: 57 (actual)

## Conditions studied

- Immunologic Deficiency Syndromes

## Interventions

- **DRUG:** Immune Globulin Intravenous (Human) Omr-IgG-am IGIV

## Key facts

- **NCT ID:** NCT00468273
- **Lead sponsor:** FFF Enterprises
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-05
- **Final completion:** 2009-08
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2014-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00468273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00468273, "A Clinical Study of Intravenous Immunoglobulin". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00468273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*